Sentences with phrase «at the current price in»

Benefits cost the government # 87 billion in 2009/10, compared to just # 28 billion at current prices in 1978/9.

This is exactly what a future contract does, as you agree with a second party to sell your Bitcoin at the current price in 4 weeks.

Not exact matches

«The current pace of repricing in fed funds is not immediately problematic for the Fed and there is yet time to price more into the curve, though we'd argue that at the June meeting, it's likely the markets will have to come to grips with the possibility of a fourth hike in 2018 and price more appropriately,» Lyngen said.

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

It will be priced $ 299.99 in the United States, the same as Nintendo «s current Wii U console, whereas in Japan, it will cost about 20 % over its predecessor at 29,980 yen.

Listed Perth company AnaeCo has announced plans for a $ 21.4 million rights issue pitched at lesss than half its current share price, as it seeks to complete its first waste treatment plant in Shenton

Such statements are based on management's current views and assumptions that could ultimately prove inaccurate and are subject to risk factors such as (but not limited to) changes in raw materials prices, currency fluctuations, the pace at which cost - reduction projects are implemented and changes in general economic and financial conditions.

So by making roughly $ 2,555 a year through mining (at the current price of bitcoin), I'm on track to pay off the extra parts I bought for mining in about 230 days.

As new financial details are revealed, Uber's shareholders must consider whether to sell shares at the current $ 32.97 - per - share price that SoftBank has offered, or wait for a potential public offering in 2019.

In 2014, at least $ 387 million worth of Bitcoin was reportedly stolen from Japan's Mt. Gox exchange — coins that would be worth billions of dollars at current prices.

But Waghorn says Hess's wide range of oil reserves, including fields in Guyana, will help diversify its revenue sources in case prices stall at current levels.

SolarCity (SCTY) CTO Peter Rive told me at the event that the company will charge customers $ 5,000 for the 10 kWh unit, a price that includes installation and an inverter to convert direct current power to alternating current for use in the home.

Bob Johnson, director of photovoltaics at research firm Strategies Unlimited, in Mountain View, Calif., says PV cells may drop below their current price by 30 % or more by 2010, even without big technological advances, making the cost of solar energy competitive with conventional sources.

Marking his 13th Uncarrier promotion on Thursday at CES in Las Vegas, T - Mobile CEO John Legere also promised that for customers who sign up for the current unlimited plan, the company will never raise the price.

GIC, one of the first sovereign funds to invest in Western banks during the global financial crisis, retains the other major investment made at the time, a stake in Citigroup which is profitable at current prices.

The current limit of INR 2 lakh is insignificant given the ticket sizes in cities, especially in bigger metros like Mumbai, where an overwhelming majority of the available housing is priced at, or above, INR 1 crore.

And the new, heftier cost won't hit everyone — existing Basecamp customers will be grandfathered in at their current prices.

For instance, a company may give an employee the right to buy 100 shares at the current price of $ 10 per share in 1998.

HelloFresh sold 31 million new shares in an initial public offering, giving it a valuation around 1.7 billion euros at current prices — more than double the $ 888 million (763 million euro) market capitalization of struggling Blue Apron (aprn).

Citi's comments come as oil prices have recovered from a plunge in 2014 with the bank seeing the first stop for the rally at about US$ 65 a barrel, around 25 % more than current price levels.

The central bank said the measures, which will make it harder for first - time buyers to obtain loans big enough to buy a decent house at current prices, might hurt the economy in the short term.

Jason Kirby at Maclean's wrote about a fellow who foresaw the collapse of oil prices and now predicts future assessments of current data will show the U.S. was in a recession at the start of 2016.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

These risks include, in no particular order, the following: the trends toward more high - definition, on - demand and anytime, anywhere video will not continue to develop at its current pace or will expire; the possibility that our products will not generate sales that are commensurate with our expectations or that our cost of revenue or operating expenses may exceed our expectations; the mix of products and services sold in various geographies and the effect it has on gross margins; delays or decreases in capital spending in the cable, satellite, telco, broadcast and media industries; customer concentration and consolidation; the impact of general economic conditions on our sales and operations; our ability to develop new and enhanced products in a timely manner and market acceptance of our new or existing products; losses of one or more key customers; risks associated with our international operations; exchange rate fluctuations of the currencies in which we conduct business; risks associated with our CableOS ™ and VOS ™ product solutions; dependence on market acceptance of various types of broadband services, on the adoption of new broadband technologies and on broadband industry trends; inventory management; the lack of timely availability of parts or raw materials necessary to produce our products; the impact of increases in the prices of raw materials and oil; the effect of competition, on both revenue and gross margins; difficulties associated with rapid technological changes in our markets; risks associated with unpredictable sales cycles; our dependence on contract manufacturers and sole or limited source suppliers; and the effect on our business of natural disasters.

Indications of some slowdown in the company's growth trajectory appear to have caused some investors to lose interest, but I think that the business's prospects are underappreciated at current prices given its competitive position and favorable tailwinds.

«It's likely that a deal (with Gannett) will get done in the end and probably at a little higher premium» than the current offer price, he said.

«At appropriate prices — and that means at a very low multiple of current earnings — we will purchase more papers of the type we like,» Buffett wrote in 201At appropriate prices — and that means at a very low multiple of current earnings — we will purchase more papers of the type we like,» Buffett wrote in 201at a very low multiple of current earnings — we will purchase more papers of the type we like,» Buffett wrote in 2013.

With virtually identical market capitalization (the price it would take to buy all shares of a company's outstanding common stock at the current market value), what exactly is an investor in each respective firm getting for his or her money?

The company in August sold 1.5 million unregistered shares to a private investor who is also a current shareholder at a price of $ 2.10 per share, for aggregate consideration of $ 3.15 million.

At its current valuation of ~ $ 67 / share, HLF has a price to economic book value ratio (price - to - EBV) of 1.2 That ratio means that the market expects only 20 % growth in NOPAT for the remainder of HLF's existence.

Natural gas - fired plants look attractive at current gas prices, certainly, but hands up — who wants a new gas plant in their neighbourhood?

The upper end of that projection — oil prices at US$ 60 — is below most of the current analyst forecasts, with expectations for the WTI price predominantly in the low US$ 50s, or below.

Still, even at the current depressed price levels, production, for the most part, in those countries is still profitable.

While Model S and X cater to the high - end luxury segment, Tesla's Model 3, which the company expects to begin delivering in late 2017, starts at about half the price of its current vehicle lineup.

At price levels below $ 80 a barrel, you can expect to see the current frantic pace of drilling in the region start to gear down.

To justify the current price of $ 47 / share, Jarden must grow NOPAT by 13 % compounded annually for the next 16 years, at which point, Jarden would be generating over $ 66 billion in revenue.

Prices for important commodities remain high and the nation's terms of trade are at an all - time high in the current quarter.

The reality is that one doesn't need interest rates reasonably estimate 10 - year prospective market returns, just as one doesn't need interest rates to calculate that a $ 100 expected payment in 10 years, at a current price of $ 65, will result in an expected total return of 4.4 % over the coming decade.

In 2002, Bezos did give his shares worth $ 500 million at current prices for charitable missions.

At the same time, the current level of the exchange rate represents a big shift in relative prices, which should provide substantial ongoing assistance for the export sector (and the import - competing sector).

But given the actual market conditions which remain in place, it's difficult to imagine just what investors are hoping for - and what they think their money is actually buying - when they purchase stocks at current prices.

Gold, iron ore and oil prices are seeing a rebound at the moment with many analysts believing that commodity prices have «bottomed out» and are eyeing gains, but Goldman Sachs has issued a warning on the current surge in commodities arguing that it is «not sustainable.»

Through these schemes, Shkreli obtained over $ 5.6 million in cash and Retrophin shares or the use of Retrophin shares worth over $ 59 million (at current market prices).

In this February 22 post on our trading blog, which was published immediately following two days of heavy selling on February 20 and 21, we said, «If and when the S&P attempts to bounce from its current level, the subsequent price and volume action that immediately follows any recovery attempt will be extremely important at -LSB-...]

As a result of these agreements, Retrophin paid $ 200,000 in cash and issued 581,000 shares to MSMB investors, resulting in a benefit to Shkreli of over $ 17.3 million (at current market prices), and is embroiled in an arbitration with Rosenfeld in which Rosenfeld is seeking $ 1,650,000.

The consortium of buyers have about four weeks to lock in enough investors at the current share price or to offer a higher price.

(f) by causing Retrophin to enter into the Yaffe Consulting Agreement, as a result of which Retrophin paid $ 200,000 in cash and issued 15,000 shares to Yaffe, resulting in a benefit to Shkreli of more than $ 600,000 (at current market prices).

As a result of these agreements, Retrophin paid out $ 2.8 million in cash and issued 11,000 Retrophin shares, and Shkreli diverted an additional 47,610 Retrophin shares for the benefit of himself and his MSMB Funds, resulting in a benefit to him and to them of more than $ 4.5 million (at current market prices).1

Marriott Vacation Club, a global leader in vacation ownership, has completed the sale of the hotel component of the Surfers Paradise Marriott Resort & Spa in Queensland, Australia to Bensonlily Surfers Paradise Pty Ltd for a gross sale price of $ 70 million AUD (approximately $ 50 million USD at current exchange rates).

(i) by causing Retrophin to commence a litigation against Doe in order to coerce Doe into giving Shkreli Doe's Fearnow Shares, and by causing Retrophin to enter into a settlement with Doe whereby Retrophin paid $ 100,000 and Doe delivered 50,000 shares to Shkreli, resulting in a benefit to Shkreli of more than $ 1.4 million (at current market prices).